how many americans take glp-1 drugs Nearly 12% of have used drugs—such as Ozempic—for weight loss. 14% say they're interested in them. New findings from the largest and most recent survey on Americans' use of a Chart: Most Americans Prefer Exercise

In addition to stimulating insulin secretion, GLP-1 has been shown to promote pancreatic islet neogenesis, differentiation, and suppression of -cell apoptosis in rodent models (70)

doi: 10.3390/nu11081776

2023;6(5):e2314493

Food and Drug Administration (FDA) has added a new warning to the weight-loss medication Wegovy, highlighting potential gastrointestinal reactions and stressing that individuals with severe gastroparesis should not take Wegovy

Large, randomized clinical trials of GLP-1 receptor agonists have had positive or at worst neutral results in terms of preventing major adverse cardiovascular events in patients with type 2 diabetes who either had cardiovascular disease at baseline or were at high risk of it

Hospitals are involved in many clinical trials assessing GLP-1 agonists